Dasgupta A, Malhotra D, Levy H, Marcadis D, Blackwell W, Johnston D
Department of Pathology, University of New Mexico Health Sciences Center, Albuquerque 87106, USA.
Life Sci. 1997;60(4-5):335-40. doi: 10.1016/s0024-3205(96)00634-0.
Oxidative stress (when free radical generation exceeds antioxidant defense) occurs in many human diseases and makes significant contributions to their pathogenesis. We automated assays estimating the antioxidant status of serum, and lipid hydroperoxide concentrations using the Monarch analyzer. In this assay, the antioxidant status of serum is measured by its ability to inhibit generation of free radicals from 2,2'-amino-di-[3-ethylbenzthiazole sulphonate] by metmyoglobin and hydrogen peroxide. The assay for measuring lipid peroxidation products in serum utilizes the ability of lipid hydroperoxides to generate methylene blue from 10N-methylcarbamyl 3,7-dimethylamino 10H-phenothiazine. We detected no lipid hydroperoxide in sera obtained from 24 controls. The mean antioxidant status was 1.69 mmol/l (SD; 0.20 mmol/l) in controls. The antioxidant capacity of serum was significantly reduced in sera of critically ill patients in the medical intensive care unit (mean = 1.05, SD = 0.26 mmol/l) with p value less than 0.05 by independent t-test, two tailed. Lipid peroxidation products were not significantly elevated in critically ill patients, however lipid peroxidation products were significantly elevated in hemodialysis patients (mean = 1.40, SD = 0.47 mumol/l) and in some kidney transplant recipients. We conclude that antioxidant capacity of sera in critically ill patients is significantly reduced.
氧化应激(当自由基生成超过抗氧化防御时)在许多人类疾病中都会出现,并对其发病机制有重大影响。我们使用Monarch分析仪实现了估算血清抗氧化状态和脂质过氧化氢浓度的自动化检测。在该检测中,血清的抗氧化状态通过其抑制高铁肌红蛋白和过氧化氢从2,2'-氨基-二-[3-乙基苯并噻唑磺酸盐]生成自由基的能力来衡量。检测血清中脂质过氧化产物的方法利用了脂质过氧化氢从10N-甲基氨基甲酰3,7-二甲基氨基10H-吩噻嗪生成亚甲蓝的能力。我们在从24名对照者获得的血清中未检测到脂质过氧化氢。对照组的平均抗氧化状态为1.69 mmol/l(标准差;0.20 mmol/l)。通过独立双尾t检验,医学重症监护病房中重症患者血清的抗氧化能力显著降低(平均值 = 1.05,标准差 = 0.26 mmol/l),p值小于0.05。重症患者的脂质过氧化产物没有显著升高,然而血液透析患者(平均值 = 1.40,标准差 = 0.47 μmol/l)和一些肾移植受者的脂质过氧化产物显著升高。我们得出结论,重症患者血清的抗氧化能力显著降低。